Go Pro

This company has been marked as potentially delisted and may not be actively trading.

Assertio (ASRT) Stock Forecast & Price Target

Assertio logo
Get the Latest News and Ratings for ASRT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Assertio and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASRT Analyst Ratings Over Time

TypeCurrent Forecast
7/25/25 to 7/25/26
1 Month Ago
6/25/25 to 6/25/26
3 Months Ago
4/26/25 to 4/26/26
1 Year Ago
7/25/24 to 7/25/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$22.65$22.65$18.00$41.25
Forecasted Upside-3.62% Downside-3.62% Downside-0.22% Downside271.62% Upside
Consensus RatingReduceReduceHoldBuy

ASRT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ASRT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Assertio Stock vs. The Competition

TypeAssertioMedical CompaniesBroader Market
Consensus Rating Score
1.80
2.29
2.52
Consensus RatingReduceHoldModerate Buy
Predicted Upside-3.62% Downside974.40% Upside14.30% Upside
News Sentiment Rating
Neutral News

See Recent ASRT News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/13/2026
Thomas Flaten
Thomas Flaten
5 of 5 stars
Reiterated RatingHold$21.80 ➝ $23.50+0.81%
5/5/2026
HC Wainwright logo
HC Wainwright
4 of 5 stars
Raghuram Selvaraju
5 of 5 stars
Reiterated RatingNeutral$18.00 ➝ $21.80+0.88%
4/20/2026
Weiss Ratings logo
Weiss Ratings
5 of 5 stars
 Reiterated RatingSell (D-)
4/9/2026 DowngradeStrong-BuyHold
3/6/2026 DowngradeStrong-BuyHold
5/13/2025 Reiterated RatingBuy
3/14/2025 Set Target$26.25+142.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:08 PM ET.


ASRT Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Assertio is $22.65, with a high forecast of $23.50 and a low forecast of $21.80.

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Assertio in the last year. There is currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" ASRT shares.

According to analysts, Assertio's stock has a predicted downside of -3.62% based on their 12-month stock forecasts.

Assertio has been rated by research analysts at HC Wainwright, and Lake Street Capital in the past 90 days.

Analysts like Assertio less than other "medical" companies. The consensus rating for Assertio is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how ASRT compares to other companies.


This page (NASDAQ:ASRT) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners